ECS successfully completes $1.95m placement
Filed with ASX · · 2 pages · English
ECS Botanics Holdings Ltd (ASX: ECS) (“ECS” or the “Company”), a leading medicinal cannabis company, is pleased to advise it has received binding commitments to raise approximately A$1.95 million (before costs) through the issue of approximately 300 million new fully paid ordinary shares at A$0.0065 per share (the “Placement Price”). The Placement was well supported by new and existing institution
Ecs Botanics Holdings Ltd on 6ix
Story so far
Earlier from Ecs Botanics
- Trading Halt
- ECS FY25 Results
- Appendix 4E & Annual Report
- ECS to support UWA medicinal cannabis clinical trial
- Terphogz Launch
Later from Ecs Botanics
- ECS Launches Sugar-Free Gummies as B2C Sales Surpass 60%
- ECS launches Woman Health Brand
- ECS Botanics advances preparations for US market entry
- Quarterly Activities/Appendix 4C Cash Flow Report
- Security Class Suspension from Quotation - ECSO
Follow Ecs Botanics into a list and get an email when it puts out news.
Follow Ecs Botanics